| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Checkpoint Therapeutics Inc (NASDAQ: CKPT)
CKPT Technical Analysis
5
| As on 8th May 2025 CKPT STOCK Price closed @ 4.14 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 2.13 & Strong Buy for SHORT-TERM with Stoploss of 2.25 we also expect STOCK to react on Following IMPORTANT LEVELS. |
CKPTSTOCK Price
| Open | 4.14 | Change | Price | % |
| High | 4.16 | 1 Day | -0.01 | -0.24 |
| Low | 4.14 | 1 Week | 0.04 | 0.98 |
| Close | 4.14 | 1 Month | 0.08 | 1.97 |
| Volume | 706140 | 1 Year | 2.06 | 99.04 |
| 52 Week High 4.39 | 52 Week Low 1.39 | ||||
NASDAQ USA Most Active Stocks
| AMRS | 0.14 | 100.00% |
| DGLY | 0.06 | 20.00% |
| GNLN | 0.01 | 0.00% |
| NVDA | 117.37 | 0.26% |
| LMDX | 0.02 | 0.00% |
| PLUG | 0.85 | 8.97% |
| AKTS | 0.04 | 0.00% |
| TSLA | 284.82 | 3.11% |
| ZKIN | 2.52 | 123.01% |
| VEEE | 7.45 | 192.16% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| CKPT Daily Charts |
CKPT Intraday Charts |
Whats New @ Bazaartrend |
CKPT Free Analysis |
|
|
CKPT Important Levels Intraday
| RESISTANCE | 4.18 |
| RESISTANCE | 4.17 |
| RESISTANCE | 4.16 |
| RESISTANCE | 4.15 |
| SUPPORT | 4.13 |
| SUPPORT | 4.12 |
| SUPPORT | 4.11 |
| SUPPORT | 4.10 |
CKPT Forecast May 2025
| 4th UP Forecast | 8.5 |
| 3rd UP Forecast | 7.1 |
| 2nd UP Forecast | 6.24 |
| 1st UP Forecast | 5.37 |
| 1st DOWN Forecast | 2.91 |
| 2nd DOWN Forecast | 2.04 |
| 3rd DOWN Forecast | 1.18 |
| 4th DOWN Forecast | -0.22 |
CKPT Weekly Forecast
| 4th UP Forecast | 5.68 |
| 3rd UP Forecast | 5.19 |
| 2nd UP Forecast | 4.88 |
| 1st UP Forecast | 4.58 |
| 1st DOWN Forecast | 3.70 |
| 2nd DOWN Forecast | 3.40 |
| 3rd DOWN Forecast | 3.09 |
| 4th DOWN Forecast | 2.60 |
CKPT Forecast2025
| 4th UP Forecast | 10.19 |
| 3rd UP Forecast | 8.25 |
| 2nd UP Forecast | 7.05 |
| 1st UP Forecast | 5.85 |
| 1st DOWN Forecast | 2.43 |
| 2nd DOWN Forecast | 1.23 |
| 3rd DOWN Forecast | 0.03 |
| 4th DOWN Forecast | -1.91 |
Checkpoint Therapeutics Inc ( NASDAQ USA Symbol : CKPT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
CKPT Business Profile
Checkpoint Therapeutics, Inc., a clinical-stage immuno-oncology biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302, a human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells. It is also developing CK-101, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a treatment for patients with EGFR mutation-positive non-small cell lung cancer; CK-103, a selective and potent small molecule inhibitor of bromodomain and extra-terminal bromodomains; and anti-carbonic anhydrase IX (CAIX) antibody, a fully human preclinical antibody to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. Checkpoint Therapeutics, Inc. has collaboration agreements with TG Therapeutics, Inc. to develop and commercialize certain assets in connection with its licenses in the field of hematological malignancies. The company was incorporated in 2014 and is based in New York, New York. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc. Address: 2 Gansevoort Street, New York, NY, United States, 10014
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service